Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Novartis Pharmaceuticals Corporation, Pharmacogenetics Department, 9 West Watkins, Gaithersburg, MD 20878, USA. mihael.polymeropoulos@pharma.novartis.com
Several genetic factors have been recently recognized as related to the etiology of Parkinson's disease. Mutations in the genes coding for alpha-synuclein and ubiquitin carboxy-terminal hydrolase have been identified in families with autosomal dominant Parkinson's disease. Mutations in the Parkin gene are responsible for autosomal recessive parkinsonism. These first pieces of the molecular puzzle of Parkinson's disease offer novel insights into the pathophysiology of the illness.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on